antipsychotics

Stop sign
Pharma

FDA advisors overwhelmingly reject Lundbeck, Otsuka's PTSD drug

The overwhelmingly negative vote came as a bit of a surprise given that several experts hinted that the combo may potentially be effective.
Angus Liu Jul 21, 2025 11:34am
Boerner

Bristol Myers CEO stays bullish on Cobenfy despite trial flop

Jun 12, 2025 12:43pm
schizophrenia bipolar disorder neuropsychiatry

BMS partner Zai Lab eyes China filing for KarXT after trial win

Oct 29, 2024 1:59pm
A concept image to illustrate mental health medications Models of a pink brain and two white pills which are about the size

Intra-Cellular moves closer to Caplyta depression expansion

Apr 16, 2024 2:27pm
Rovi

Rovi wins FDA nod to make Moderna's COVID shot at Spanish plant

Feb 28, 2024 11:22am
Injection

Teva taps Royalty to bankroll long-acting schizophrenia drug

Nov 13, 2023 11:40am